Bioeng Transl Med January 2023 PMID 36684100

Chitosan-based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy.

Milad Ashrafizadeh, Kiavash Hushmandi, Sepideh Mirzaei, Saied Bokaie, Ashkan Bigham, Pooyan Makvandi, Navid Rabiee, Vijay Kumar Thakur, Alan Prem Kumar, Esmaeel Sharifi, Rajender S Varma, Amir Reza Aref, Marcin Wojnilowicz, Ali Zarrabi, Hassan Karimi-Maleh

Download social card

Mentions

Peak: 38 in Sep 2022

across 2 sources since Mar 2022

Extended reach

411,817

potential audience

Total likes

209

Video views

152

Mentions per month

Mar 2022 – May 2023

Where it's discussed

X / Twitter58 posts
YouTube2 videos

AI synopsis

What people are saying

The discussions highlight the importance of chitosan-based nanosystems in delivering chemotherapy, as seen in comments about the article's role in advancing cancer therapy. Words like 'collaborative work' and references to journal impact demonstrate recognition of its scientific value and potential influence on biomedical research.

AgreementModerate agreement

The discussions generally acknowledge the significance of the publication, with some posts explicitly supporting its findings and potential applications.

InterestModerate interest

Posts reflect a moderate level of interest, focusing on the publication's content and implications without extensive elaboration.

EngagementModerate engagement

Participants engage by sharing their publication experiences and emphasizing the relevance of nanotechnology in cancer treatment, indicating a moderate depth.

ImpactModerate impact

The renewed attention and references in social discussions suggest a noteworthy impact, especially considering the publication's publication in a high-impact journal.

Abstract in brief

The text discusses how chitosan-based nanoparticles are promising tools for delivering chemotherapy drugs like doxorubicin in cancer treatment, benefiting from their biocompatibility, ability to target cancer cells, and overcome drug resistance.
These nanoparticles can be used to co-deliver doxorubicin with other agents such as curcumin, cisplatin, or gene-silencing molecules, enhancing the effectiveness of cancer therapy through synergistic effects and tumor suppression.
Various types of functionalized chitosan nanoparticles, including those responsive to pH, redox, or light, are being developed to improve targeted delivery and drug release profiles, with the potential for clinical use in cancer treatments soon on the horizon.]

Read the full abstract

All mentions

Chitosan Nanoscale Systems for Doxorubicin Delivery in Cancer Therapy

This video explores the use of chitosan-based nanoscale systems for the delivery of doxorubicin, addressing their potential in cancer therapy. It highlights keywords such as drug resistance, gene therapy, and…

STEM RTCL TV · May 4, 2023 104 views

Chitosan-based Nanoscale Systems for Doxorubicin Delivery

This video explores chitosan-based nanoscale systems designed for effective doxorubicin delivery in cancer therapy. Focused on advancements in gene therapy and drug resistance, it discusses stimuli-responsive…

STEM RTCL TV · May 4, 2023 48 views

Cardio-Targets

@CardioTargets · X

Chitosan-based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy https://t.co/VXC1KcOYKp

Jan 23, 2023 · 153 followers View post →

amilkar lipa

@amilkarli · X